Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
capivasertib
×
30 days
×
Clear all
Filters
3
NCT06982521
2026-03-03
ReDiscover-2
Relay Therapeutics, Inc.
Phase 3
Recruiting
540 enrolled
NCT07281833
2026-02-27
CAPIcorn
West German Study Group
Phase 3
Recruiting
250 enrolled